Figure 1.
Figure 1. SDS-PAGE and fibrinopeptide release curves of normal and BβArg14His fibrinogens. (A) Thrombin-catalyzed release of FpA (squares) and FpB (circles) from normal [▪, •] and BβArg14His (□, •) fibrinogens. (B) Batroxobin-catalyzed release of FpA from normal (▪) and BβArg14His (•) fibrinogens. Conditions: 0.1 mg/mL fibrinogen, 0.1 U/mL thrombin or 0.005 U/mL Batroxobin in 20 mM HEPES, pH 7.4, 150 mM NaCl. (inset) 10% reducing SDS-PAGE gel of normal (lane 1) and BβArg14His (lane 2) fibrinogens, with molecular weight markers indicated on left.

SDS-PAGE and fibrinopeptide release curves of normal and BβArg14His fibrinogens. (A) Thrombin-catalyzed release of FpA (squares) and FpB (circles) from normal [▪, •] and BβArg14His (□, •) fibrinogens. (B) Batroxobin-catalyzed release of FpA from normal (▪) and BβArg14His (•) fibrinogens. Conditions: 0.1 mg/mL fibrinogen, 0.1 U/mL thrombin or 0.005 U/mL Batroxobin in 20 mM HEPES, pH 7.4, 150 mM NaCl. (inset) 10% reducing SDS-PAGE gel of normal (lane 1) and BβArg14His (lane 2) fibrinogens, with molecular weight markers indicated on left.

Close Modal

or Create an Account

Close Modal
Close Modal